chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pneumonia; Initial information was received on 21-Jan-2021 regarding an unsolicited valid serious case from a consumer/non-health care professional.  This case involves an 87 years old male patient who had a fatal pneumonia, while he received INFLUENZA VACCINE.  It is unknown if the patient had any medical history, concomitant disease or risk factor.  Medical treatment(s), past vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (batch number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination  On an unknown date, the patient developed a serious pneumonia (unknown latency) following the administration of INFLUENZA VACCINE. This event was assessed as medically significant and was leading to death.  The patient was full of hair, most of his teeth and healthy to his last year with no flu shot ever until the last year.  It is unknown if the patient experienced any additional symptoms/events   There were no laboratory data/results available.  It was not reported if the patient received a corrective treatment before death.  At the time of report, the outcome of event was fatal  It is unknown if an autopsy was done. The cause of death was Pneumonia.  Information on batch number was requested for this case; Sender's Comments: This poorly documented case, involves an 87 years old male patient who had a fatal pneumonia following the administration of INFLUENZA VACCINE (unknown manufacturer). The time to onset was unknown. Additional information regarding patient's medical history, condition at the time of vaccination, concomitant medications, lab /radiological investigation excluding other etiologies and detailed autopsy report would be needed for complete assessment of the case. Based upon the reported information, the role of vaccine cannot be assessed; Reported Cause(s) of Death: pneumonia
devel diffuse induration & erythema involving whole LUE & fever 103.5 & leukocytosis;adm to hosp;
Patient awoke morning after vaccination with grand mal seizure.  Her mother took her to a local hospital and she was transferred to another hospital and then to another.  MR received from 1st ER visit which reveals a 15 yr old brought in by her mother with c/o confusion, disorientation, and facial distortion on the morning following her Gardasil vax.  PE:  Significant for confusion and disorientation, otherwise normal. Patient was transfered to another hospital to be followed by a pediatric neurologist, Clinical impression : Altered mental status. MR received from 2nd hospital.  Pt. transfered to PICU with a diagnosis of altered mental status. Still somewhat confused but improving upon admission. Improvement in mental status over the next 24 hours and she was transfered to a regular pediatric floor, oriented x3 and with no focal deficits. Discharge DX: New onset seizures (probably 2' to hypoglycemia per face sheet).
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age.  No information was provided regarding concurrent conditions, medical history, or concomitant medications. On or about 01-JAN-2012, a pharmacist at a pharmacy administered ZOSTAVAX to the patient to obtain permanent prevention and protection against shingles and zoster-related injuries/conditions (dose, route, and lot # not provided). On or about 01-JAN-2016, the patient was treated by healthcare providers at a family medicine office for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with ZOSTAVAX, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of ZOSTAVAX, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was not recovered. Causality assessment was related. Additional information has been requested.
Patient had seizure on 9/04/21 at the following times 9:25am, 12:00am, and 12:36pm. Mother took to ER where they gave fluids and then discharged. After coming home patient had another seizure on 9/4/21 at 6:29pm. Since then no additional seizures, as of time of reporting.
Felt sick all day; Couldn't ate; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Felt sick all day) and DECREASED APPETITE (Couldn't ate) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unk) for COVID-19 vaccination.     The patient's past medical history included COPD since an unknown date. Concurrent medical conditions included Asthma and Hypertension.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ILLNESS (Felt sick all day) and DECREASED APPETITE (Couldn't ate). At the time of the report, ILLNESS (Felt sick all day) and DECREASED APPETITE (Couldn't ate) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was provided.  No treatment details were provided.    Most recent FOLLOW-UP information incorporated above includes: On 01-May-2021: NNI
Body aches and other flu-like symptoms that were quite severe.  Slight headache Symptoms started within 4 hours of vaccination.  This is second day since the shot.  Still have symptoms but they are not as severe.
Case number PHEH2014US025011 is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 34 years old female patient. Past medical history and concomitant medications were not reported. The temperature excursion of FLUVIRIN (batch number: 145701) began around 16 Oct 2014 and the patient received the vaccine intramuscularly at a dose of 0.5 ml on 30 Oct 2014. It was reported that the vaccine administered was at 49 F 12 times over a period of 34 days. There were 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46 to 49 F during each of those excursions. No adverse events were reported following the maladministration.
This case was reported by a physician via a sales representative and described the occurrence of decreased therapeutic response in a 15-year-old subject of unspecified gender who was vaccinated with ENGERIX B (GlaxoSmithKline). On unspecified dates the subject received 3rd dose, 2nd dose and 1st dose of ENGERIX B (infant series). At the age of 15, the subject was tested for antibodies to hepatitis B and the subject did not have detectable levels. This was considered to be decreased therapeutic response. The physician reported to the sales representative that this event occurred in about 15 to 20 percent of 15 year olds checked for hepatitis B antibodies.
Within 2 hours of receiving the vaccine I got shortness of breath. My right leg was swollen from the knee down to my foot. I contacted my doctor. The doctor ran some tests. The doctor said I had pneumonia and extensive blood clots up and down my right leg from the groin down to my ankle. My doctor prescribed a strong antibiotic to treat the pneumonia and Xarelto for the blood clots. The pneumonia cleared within 1 month. I was on Xarelto for about 1 year. The blood clots in my right leg have mostly cleared except for the the spot behind my knee so the doctor said I could come off of the Xarelto. Now I am only taking a low dose aspirin once per day. During the one month when this started I was able to work from home but couldn't participate in anything with strenuous activity. I was limited to mostly only do tings at my desk. After the pneumonia cleared I felt normal again. I started to feel like myself towards the end of May 2021. I started back working out again back to normal. After receiving the Covid vaccine as well my brother had developed blood clots in his lung and was hospitalized. Now he is recovered from it.
After the pt received her 2nd dose of the COVID19 vaccine while sitting in observation she reported feeling "queasy." Also reported feeling like her heart was beating fast. Pt was evaluated by RN and  EMS paramedic. BP 195/83 and repeat 175/129. HR 76 and 83. Per RN and EMS pt seemed to be in a-fib. Pt states her MD recently took her off of medication for a-fib.  Pt was advised to go with EMS to the ED. Pt refused despite counseling and encouraging her to go an be evaluated.  Pt signed refusal for transport with EMS. Pt's daughter came into clinic to walk her out. RN discussed with pt's daughter and reiterated the recommendation for ED eval. RN also advised both the pt and her daughter to call her PCP and speak with the oncall MD for further recommendations since she is refusing transport to ED. Pt and her daughter verbalized understanding.
TC from pt 26JAN96 c/o nausea & bloody nose 22JAN96;24JAN96 c/o flu-like sx,stiff neck,muscle aches shoulders,back,knees,t100-103 (temp abated 25JAN96);saw MD & inj of pred given & oral pred to take home & contact MD if no improvement
he had arm pain; underarm pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 11 year-old male patient received bnt162b2 (BNT162B2), intramuscular (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "he had arm pain"; AXILLARY PAIN (non-serious), outcome "unknown", described as "underarm pain". It was unknown if therapeutic measures were taken as a result of pain in extremity, axillary pain.  Additional information: After the vaccine, the child said he had arm pain, including underarm pain. This occurred for a few days after the vaccination. Patient had not covid prior vaccination. Patient had not covid tested post vaccination.  Follow-up attempts are completed. No further information is expected.
Swelling of RA, chills, pain developed on 9-1, got Rx for Amoxicillin (cellulitis).
Low grade fever, fussiness, cough within 24hrs of vaccine. Appears to be influenza-like illness.
FEEL LIKE GOT RAN OVER BY A CAR/DAY BEING ROUGH; SORENESS EVERYWHERE; LIGHTHEADED; SHORTNESS OF BREATH; REALLY BAD CHILLS; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 07-JUL-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On 08-JUL-2021, the subject experienced feel like got ran over by a car/day being rough. On 08-JUL-2021, the subject experienced soreness everywhere. On 08-JUL-2021, the subject experienced lightheaded. On 08-JUL-2021, the subject experienced shortness of breath. On 08-JUL-2021, the subject experienced really bad chills. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from feel like got ran over by a car/day being rough, soreness everywhere, lightheaded, shortness of breath, and really bad chills. This report was non-serious.
Child was given a Pfizer Bivalent Booster vs a Pfizer 5-11 primary dose.  Child cried prior to , during and after vaccine.  No signs or symptoms noted after vaccine.  Child was anxious when we notified mother of vaccine administration error.  History of medical conditions was difficult due to child crying.  Child was sent home.  RN will call mom to check on child tomorrow.  Child is now scheduled to come of Friday for follow up check.
Patient received her first COVID-19 shot on 6/26/21 and called today to report that the swelling, redness, knot, heat, and pain in her arm still persist. She also said she has pain in her leg as well as heart palpitations. She did say that she's had heart palpitations in the past. These symptoms started about 2-3 days ago, she also said. I advised her to take Tylenol and to use a cold compress. She said she did not have plain Tylenol on hand and would take Tylenol, which she takes for arthritis. I advised her to try to get some plain Tylenol but to take what she had if she was in pain and could not wait. I also advised her to follow up with her doctor, especially regarding the palpitations. She said she would follow the above recommendations.
first dose in 2019, inquiring for second dose; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 2019).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.  Additional details were provided as follows: The reporter was the patient. The age at vaccination was not applicable for this report. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter did not consent to follow up.
Pt called at 6:30 PM complaining of pain in both arms, raised temp, nausea and headache.
1st Dose: No abnormal symptoms 2nd Dose: normal. Had bloodwork done in-between doses, for general pain/achiness, sedimentation rate was very unusually high  on 2/10 was 46 mm per hour (normal is 20 mm per hour). Had 2nd dose on 2/13,  sedimentation rate was retested on 3/18 was even higher at 54 mm per hour. Has stayed at 54, retested on 7/19.
Anemia; severe inflammation indicated in the blood work; "felt the symptoms you would commonly get after receiving the vaccine but they are ongoing"; 2 weeks after 2nd dose was administered the pneumovax vaccine and felt achy for a week; This spontaneous case was reported by a consumer and describes the occurrence of ANAEMIA (Anemia), INFLAMMATION (severe inflammation indicated in the blood work), VACCINATION COMPLICATION ("felt the symptoms you would commonly get after receiving the vaccine but they are ongoing") and MYALGIA (2 weeks after 2nd dose was administered the pneumovax vaccine and felt achy for a week) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 010A21A) for COVID-19 vaccination.     Previously administered products included for Ache NOS: pneumovax in 2021.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2021, the patient experienced MYALGIA (2 weeks after 2nd dose was administered the pneumovax vaccine and felt achy for a week). On an unknown date, the patient experienced ANAEMIA (Anemia), INFLAMMATION (severe inflammation indicated in the blood work) and VACCINATION COMPLICATION ("felt the symptoms you would commonly get after receiving the vaccine but they are ongoing"). The patient was treated with IBUPROFEN for Adverse event, at a dose of 1 dosage form and CELECOXIB (CELEBREX) for Adverse event, at a dose of 1 dosage form. At the time of the report, ANAEMIA (Anemia), INFLAMMATION (severe inflammation indicated in the blood work), VACCINATION COMPLICATION ("felt the symptoms you would commonly get after receiving the vaccine but they are ongoing") and MYALGIA (2 weeks after 2nd dose was administered the pneumovax vaccine and felt achy for a week) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood albumin: low (Low) Low. In 2021, C-reactive protein: 77 (High) High. In 2021, Globulin: high (High) High. In 2021, Red blood cell sedimentation rate: 88 (High) 88.         Patient reported that he was taking supplements.
When I woke up that morning I noticed a red circle by injection location that was raised and hot and itchy. I called my doctor and advised them of what I was experiencing they had no clue what was going on.  No medication was recommended. No further care recommendations were provided by my doctor.
This spontaneous report as received from a healthcare worker refers to a patients of unknown age and gender. It was reported that GARDASIL, that was improperly stored since 07-APR-2014 to 22-JUL-2014, was administered to unspecified patients on unspecified dates. No adverse effects reported. This is one of several reports from the same source. Additional information has been requested.
Got up at 4am (normal), did house work, took grandson to school, went to horse ranch and did chores, went to town, into bank, into grocery store, got a car wash, and drove home. Drove 60 miles round trip no issues. Got home around 10am and my body pain hit. I slept for the next 20 hours only to drink water and go to the restroom. I only sleep about 4 or 5 hours a night. Next day, I had a headache when I stood up but it would go away. I continued my normal routine and was fine by the third day. I weigh about 170 pounds and never have been bothered by any type of vaccination, surgeries and meds and doing my own stunts. Broken legs, arms, pelvis, ribs. I do my own stunts.
Information has been received from an 18 year old female with migraine and no allergies for GARDASIL, a Pregnancy Registry product, who in February 2007, was vaccinated with the first dose of GARDASIL (lot# not reported). Concomitant therapy included vitamins (unspecified). In April 2007, the the patient received her second dose of GARDASIL (lot# not reported) 0.5 mL when she was 2 weeks pregnant. The patient requested a pregnancy test before receiving the shot of second dose however it was never given to her. On 13-FEB-2008, the patient delivered a baby. It was reported that the baby experienced unexplained fever almost every other day as well as seizures. The baby was also congested all the time and was diagnosed with asthma. The reporter felt that the baby's unexplained fever, seizures and asthma were related to therapy with GARDASIL. Unspecified medical attention was sought. Upon internal review, seizure was considered to be an other important medical event. No further information is available.
6 mo old male onset generalized erythematous maculo papular rash within 48 hours after vaccination.
Swelling at the injection site 7 days after the vaccine.  It is red, hot, and swollen.  Size of a softball.  Swelling has not receded at day 9 from first dose of moderna shot.
Large red , hot, raised rash over entire upper arm, shoulder to elbow, front to back.
slept for 2 days post second shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERSOMNIA (slept for 2 days post second shot) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HYPERSOMNIA (slept for 2 days post second shot). At the time of the report, HYPERSOMNIA (slept for 2 days post second shot) outcome was unknown.            Concomitant medications and treatment information was not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to MOD-2021-163658 (Patient Link).
Started developing painful joints. More locations as time went on. First right middle knuckle, then left middle knuckle, left shoulder, ankles, big toes, wrists, left clavicle. Went to Rheumatologist and was diagnosed with Rheumatoid Arthritis on 12/10/2012.
shingles on left face and nose; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 2 weeks after receiving Shingles vaccine, the patient experienced shingles (Verbatim: shingles on left face and nose). The outcome of the shingles was resolved (duration 2 months).   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 05-JUL-2023 This case was reported by a patient via interactive digital media. The patient stated that it was horrifying.  The follow-up could not be possible as no contact details were available.
Said he felt sick after vaccination and vomited. BP 124/82, HR 87, O2 97
After giving the pt the flu shot, she got in her mart cart and her and her daughter started leaving. They only got about 2 feet when patient stopped driving and her daughter stated the patient couldn't breathe. I went to the customer and she was struggling to breathe. I got her down on the floor because I didn't want her to pass out and hit her head. She was still struggling to breathe. At 324pm, I administered one epinephrine 0.3mg pen in her right thigh. At 327pm, her BP was 162/117. At 328pm, I administered 10ml diphenhydramine 12.5mg/5ml. Her breathing and color improved. The fire department arrived around 330pm. They took the customer to the hospital. Patient never lost consciousness and was speaking the entire time. Her lips were blue and she was pale in color.
Chills,fever,almost fainting,numbness in hands ,arms,shins,hyperventilating. Symptoms started the night of the vaccine. Went by ambulance to ED
Had blood clot in left leg. Blood in eyes. Sinus sore throat short breath congested headache vision problems. Tested positive for strep one month after receiving one vaccine been taking antibiotics for 6 days but I'm getting worse.
The arm was sore at the injection site on day 2 and 3 but then felt fine.  It became red and itchy from injection  site down to my elbow  about 10 days after the shot and remains red and itchy  on day 13.